Related Experiment Videos

Double negative (CD4/CD8) T cell receptor alpha/beta positive lymphocytes in patients with graft-versus-host disease

H G Klingemann, G L Phillips

Bone Marrow Transplantation

|May 1, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT.

Bone marrow transplantation·2015

What would Karl Landsteiner do? The ABO blood group and stem cell transplantation.

Bone marrow transplantation·2005

Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary report.

Seminars in oncology·2005

Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma.

Bone marrow transplantation·2004

Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2004

Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma.

Bone marrow transplantation·2004

See all related articles